RB 23/2023 Termination of the Buy-back Program

AmRest Holdings, SE (“AmRest”, the “Company”), in relation to the regulatory announcement no. RB 8/2023 published on 4 July 2023, relating to the program for the repurchase of its own shares approved by AmRest’s Board of Directors (the "Buy-Back Program") pursuant to the authorization granted in its favor by resolution of the AmRest General Meeting of Shareholders held on 12 May 2022 under item nine of the agenda, hereby informs that, following the last of the acquisitions referred to below, the maximum investment foreseen in the Buy-Back Program has been reached, i.e. EUR 6.3 million, which represents the acquisition of a total of 1 052 235 own shares, which represent 0.4793% of the share capital.

All acquisitions under the Buy-Back Program have been carried out and reported on a regular basis in accordance with Article 5 of Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (the "Market Abuse Regulation") and in Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Delegated Regulation").

As a consequence of the above, the Buy-Back Program is terminated.

Furthermore, and in accordance with article 5 of the Market Abuse Regulation and articles 2.2 and 2.3 of the Delegated Regulation, AmRest announces that, during the period from 16 to 23 October 2023 (both inclusive), the Company has carried out the purchases of its own shares under the Buy-back Program described in the attachments to this report.

Appendix 1 includes aggregate data, Appendix 2 includes detailed information on the transactions.

Legal act: Art. 5 Sec. 1 (b) of Regulation (EU) No 596/2014 of The European Parliament and of The Council of 16 April 2014 on market abuse (MAR) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/E